Found 42 matching trials
Specific Lp(a) Apheresis for Regression of Coronary and Carotid Atherosclerosis PHASE3 To evaluate whether specific lipoprotein(a) apheresis on the top of optimal...
Show More Location
Russian Cardiology Research and Production Center
Learn More & Join Trial
Anti-Cytokine Therapy for Vasculitis PHASE2 The purpose of this study is to determine whether Infliximab (monoclonal an...
Show More Location
University Hospitals Birmingham NHS Foundation Trust
Learn More & Join Trial
A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting N/A This is a multicenter, non-randomized, non-interventional three-cohort stud...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study Enrollment PHASE3 To evaluate the efficacy of subcutaneous (SC) evolocumab, compared to regul...
Show More Learn More & Join Trial
Scleroderma Treatment With Autologous Transplant (STAT) Study PHASE2 This phase II trial studies how well giving cyclophosphamide and anti-thymo...
Show More Location
City of Hope Comprehensive Cancer Center
Learn More & Join Trial
Effect of Lipoprotein(a) Elimination by Lipoprotein Apheresis on Cardiovascular Outcomes N/A This multicenter multinational prospective two-arm matched-pair observation...
Show More Location
University Hospital Carl Gustav Carus
Learn More & Join Trial
Prolongation of Pregnancy in Preeclampsia by Therapeutic Lipid Apheresis NA Preeclampsia is a disease which occurs in about 6-8% of all pregnancies and...
Show More Location
Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Freiburg
Learn More & Join Trial
Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation PHASE1 The purpose of this study is look at the safety of:
* Taking a specific co...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Comparisons of Two Low-density Lipoprotein Apheresis Systems in Patients With Homozygous Familial Hypercholesterolemia N/A Homozygous familial hypercholesterolemia (HoFH) is characterized by a six- ...
Show More Location
Institute of Nutrition and Functional Foods (INAF)
Learn More & Join Trial
Study of Alirocumab (REGN727/SAR236553) in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) Undergoing Low-density Lipoprotein (LDL) Apheresis Therapy PHASE3 The primary objective of the study is to evaluate the effect of alirocumab ...
Show More Location
Multiple Locations
Learn More & Join Trial